Rac deletion in osteoclasts causes severe osteopetrosis
- PMID: 22114304
- PMCID: PMC3225269
- DOI: 10.1242/jcs.086280
Rac deletion in osteoclasts causes severe osteopetrosis
Abstract
Cdc42 mediates bone resorption principally by stimulating osteoclastogenesis. Whether its sister GTPase, Rac, meaningfully impacts upon the osteoclast and, if so, by what means, is unclear. We find that whereas deletion of Rac1 or Rac2 alone has no effect, variable reduction of Rac1 in osteoclastic cells of Rac2(-/-) mice causes severe osteopetrosis. Osteoclasts lacking Rac1 and Rac2 in combination (Rac double-knockout, RacDKO), fail to effectively resorb bone. By contrast, osteoclasts are abundant in RacDKO osteopetrotic mice and, unlike those deficient in Cdc42, express the maturation markers of the cells normally. Hence, the osteopetrotic lesion of RacDKO mice largely reflects impaired function, and not arrested differentiation, of the resorptive polykaryon. The dysfunction of RacDKO osteoclasts represents failed cytoskeleton organization as evidenced by reduced motility of the cells and their inability to spread or generate the key resorptive organelles (i.e. actin rings and ruffled borders), which is accompanied by abnormal Arp3 distribution. The cytoskeleton-organizing capacity of Rac1 is mediated through its 20-amino-acid effector domain. Thus, Rac1 and Rac2 are mutually compensatory. Unlike Cdc42 deficiency, their combined absence does not impact upon differentiation but promotes severe osteopetrosis by dysregulating the osteoclast cytoskeleton.
Figures








References
-
- Clausen B. E., Burkhardt C., Reith W., Renkawitz R., Forster I. (1999). Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265-277 - PubMed
-
- Coccia P. F., Krivit W., Cervenka J., Clawson C., Kersey J. H., Kim T. H., Nesbit M. E., Ramsay N. K., Warkentin P. I., Teitelbaum S. L., et al. (1980). Successful bone-marrow transplantation for infantile malignant osteopetrosis. N. Engl. J. Med. 302, 701-708 - PubMed
-
- Del Pozo M. A., Kiosses W. B., Alderson N. B., Meller N., Hahn K. M., Schwartz M. A. (2002). Integrins regulate GTP-Rac localized effector interactions through dissociation of Rho-GDI. Nat. Cell Biol. 4, 232-239 - PubMed
-
- Eisman J. A., Bone H. G., Hosking D. J., McClung M. R., Reid I. R., Rizzoli R., Resch H., Verbruggen N., Hustad C. M., Dasilva C., et al. (2011). Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect. J. Bone Miner. 26, 242-251 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- AR032788/AR/NIAMS NIH HHS/United States
- R01 AR046523/AR/NIAMS NIH HHS/United States
- R37 AR046523/AR/NIAMS NIH HHS/United States
- AR046852/AR/NIAMS NIH HHS/United States
- R01 DK062757/DK/NIDDK NIH HHS/United States
- AR054618/AR/NIAMS NIH HHS/United States
- AR057235/AR/NIAMS NIH HHS/United States
- AR057037/AR/NIAMS NIH HHS/United States
- R01 AR032788/AR/NIAMS NIH HHS/United States
- P30 AR057235/AR/NIAMS NIH HHS/United States
- R01 AR054618/AR/NIAMS NIH HHS/United States
- S10 RR023660/RR/NCRR NIH HHS/United States
- AR046523/AR/NIAMS NIH HHS/United States
- P30 DK056341/DK/NIDDK NIH HHS/United States
- R01 AR046852/AR/NIAMS NIH HHS/United States
- DK62757/DK/NIDDK NIH HHS/United States
- R01 AR057037/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials